LONDON — AstraZeneca's AZN.L Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the ...

The Food and Drug Administration recently announced plans to phase out phenylephrine, the key ingredient some cold and ...

A device costing just pennies, based on an idea by a University of Manchester Professor to help his son use an inhaler, could ...

People taking benralizumab were significantly less likely to need further treatment for their asthma or COPD symptoms, a major clinical trial has shown ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially ...

Scientists have discovered that benralizumab, a drug currently used for severe asthma, can be repurposed in emergency settings to reduce hospitalisations and further treatment for asthma and COPD ...

Mona Bafadhel receives funding from the National Institute of Health Research, Asthma+Lung UK, and Horizon Europe. For this study, Mona Bafadhel received funding from AstraZeneca to complete the ...

A major breakthrough in asthma treatment has been achieved through the use of Benralizumab, which researchers are calling a “game-changer.” Benralizumab, the first new treatment for asthma attacks and ...

A new form of treatment for serious asthma and chronic obstructive pulmonary disease (COPD) could be “a game changer” for patients, according to respiratory experts. Doctors said the new way ...

A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a “game-changer” and is the first leap in treatment for 50 years, researchers say.

The first new treatment for asthma attacks in 50 years has been hailed as a "game-changer" by doctors and patients. A clinical trial of the drug benralizumab showed it was far more effective than ...